Sold by: Broad Institute
Open data
|
Deployed on AWS
Broad maintained human genome reference builds hg19/hg38 and decoy references.
Overview
Broad maintained human genome reference builds hg19/hg38 and decoy references.
Features and programs
Open Data Sponsorship Program
This dataset is part of the Open Data Sponsorship Program, an AWS program that covers the cost of storage for publicly available high-value cloud-optimized datasets.
Pricing
This is a publicly available data set. No subscription is required.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Open data resources
Available with or without an AWS account.
- How to use
- To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more
- Description
- This dataset includes two human genome references assembled by the Genome Reference Consortium: Hg19 and Hg38.
- Resource type
- S3 bucket
- Amazon Resource Name (ARN)
- arn:aws:s3:::broad-references
- AWS region
- us-east-1
- AWS CLI access (No AWS account required)
- aws s3 ls --no-sign-request s3://broad-references/
Resources
Vendor resources
Support
Contact
Managed By
Broad Institute
How to cite
Broad Genome References was accessed on DATE from https://registry.opendata.aws/broad-references .
License
CC0 1.0 Universal (CC0 1.0) Public Domain Dedication
Similar products
The DRAGEN Complete Suite enables ultra-rapid analysis of Next Generation Sequencing (NGS) data for large data sets, such as whole genomes, exomes, and genes/panels.
CancerVision is a cutting-edge 2-in-1 whole-genome cancer assay offering both somatic (40x) and paired germline (20x) coverage, with ultra-deep targeting (500x) of 600+ clinically relevant cancer genes. It delivers >99% sensitivity and PPV, with robust detection of complex variants including SVs, CNVs, and mutations in non-coding regions. CancerVision also provides key biomarker insights such as TMB, MSI, HRD, mutational signatures, and germline variants. This CAP/CLIA-validated assay offers a fast 2-week turnaround and supports advanced custom analyses, including ecDNA, tumor ploidy, and transposable element detection, at whole-genome resolution. Designed for precision oncology, CancerVision is your comprehensive genomic solution for cancer diagnostics and research.
Kriv AI deploys AWS HealthOmics pipelines for pharma R&D, biotech, CROs, diagnostic companies, and academic medical centers. Scope: HealthOmics Sequence / Variant / Annotation / Reference Stores, Ready2Run + private workflows (Nextflow DSL2 / WDL / CWL), variant calling (BWA-MEM + GATK + DeepVariant + Strelka2 + Mutect2), RNA-seq (STAR + Salmon + DESeq2), multi-omics integration via AWS Glue + OMOP Genomics CDM, clinical-genomic federation via AWS HealthLake + FHIR Genomics IG, 21 CFR Part 11 audit trail for CLIA LDTs + CDx, HIPAA Security Rule controls, GIAB validation, ACMG/AMP variant classification workflow. Three tiers: $100K / $175K / $275K + $40K Extra Pipeline (CRISPR screens / scRNA-seq / long-read PacBio / Oxford Nanopore / spatial transcriptomics / ChIP-seq / ATAC-seq / methylation). AWS Select + Databricks + Anthropic CPN. MDF-eligible. EDP-eligible for enterprise buyers.` (MDF-eligible language is partner-facing; buyers need EDP-eligible language)
This product has charges associated with it for seller support, integration, data use facilitation, and maintenance.